London South East | The UK's favourite investor portal.

eleaguered e-commerce company THG was one of the few companies to make gains on the stock market today as one of its most vocal critics pulled back.

Shares in THG, formerly The Hut Group, surged 23.1p, or 12.5%, to 213.8p after The Analyst, a private City research firm, reportedly withdrew its short recommendation. The same research house helped trigger the collapse in THG’s share price when it first published the note in October.

The withdrawal suggests The Analyst thinks the company’s share price doesn’t have any further to fall and the worst may be over.

THG’s share price has sunk over 65% since September amid concerns about governance and transparency. Investors became jittery after the company announced plans to spin-off its beauty division and focus instead on its nascent platform Ingenuity, which provides e-commerce services to other brands.

CEO Matt Moulding has sought to address City concerns by giving up his golden share, which gave him control of the business, appointing a new non-executive director and vowing to appoint an independent chair.

Moulding has blamed short sellers for the firm’s woes.

Around 1.3% of THG’s stock is on loan to short sellers, according to official disclosures, up from around 1% when The Analyst first issued its short recommendation.

On Friday, analysts at Bank of America said THG’s stock looked “just too cheap” after the recent sell-off.

“We value each of the group’s three division at a higher [enterprise value] than the overall group market cap,” the bank wrote. “We believe the listing of Beauty could act as a catalyst for the shares, while the company has done [sic] good progress when it comes to governance and transparency.”

Last week THG announced that Matalan had signed up to use its Ingenuity platform, one of the biggest wins for the division to date.

NS Number : 1078W

Hurricane Energy PLC

17 December 2021

17 December 2021

Hurricane Energy plc

("Hurricane" or the "Company")

Greater Warwick Area Update
Hurricane Energy plc, the UK based oil and gas company, provides an update on its activities in the Greater Warwick Area ("GWA").

As announced on 14 October 2021, the GWA Joint Venture ("JV") has been engaging with the Oil & Gas Authority (the "OGA") on the technical re-evaluation and interpretation of the GWA licence potential, and requesting a regulatory amendment of the obligation to drill a well on the P1368(S) Lincoln licence, which must be commenced on or before 30 June 2022, to a later commencement date . The OGA has indicated, as part of its considerations, that it is not content to support a deferral of the obligation well unless the GWA JV partners satisfy the OGA that they will be able to fund an obligation well in a timely manner.

In parallel with these discussions with the OGA, t he Company has been exploring options to realise value for its equity share of the GWA assets, including through third party funding for the drilling of the Lincoln obligation well. To date, discussions with external parties have not resulted in formalising any interest to secure third party investment in the GWA assets.

The Company notes the announcements on 8 December 2020 by Spirit Energy and its largest shareholder, Centrica plc, regarding the strategic focus of its remaining UK assets and the limitation of any further investment in exploration and appraisal.

Following discussions within the JV, the GWA JV has elected to continue its plans to suspend further funding towards well planning and drilling of the obligation well on Lincoln in 2022 . However, funds continue to be made available in 2022 to promote the area's prospectively.

Given both the Company's financial circumstances and the related challenges of securing additional funding for the Lincoln obligation well, the Company currently believes there is a reasonable prospect that, unless the Company can secure an alternative source of funds, the GWA JV will be unable to either drill the obligation well in 2022 or to obtain a deferral of the obligation well. As such, it is reasonably probable that the P1368(S) licence sub area will be relinquished on or before 30 June 2022.

In the event that the P1368(S) licence sub area is relinquished, the carrying value of the Lincoln asset in the Company's accounts of c.$54 million would be impaired and a non-cash impairment charge recognised.

The Company will continue to actively explore potential options over the coming months to retain the P1368(S) Lincoln Licence. Further updates will be provided in due course.

-ends-

Eurasia Mining Plc

Tier-1 scale JORC MRE at NKT ex-operating Ni mine

Eurasia Mining Plc ("Eurasia" or the "Company"), the palladium, platinum, rhodium, iridium and gold producing company, is pleased to announce a tier-1 scale JORC Mineral Resource Estimate ("MRE") by Wardell Armstrong International ("WAI") at Nittis-Kumuzhya-Travyanaya ("NKT") nickel dominant nickel-copper-PGM mine formerly operated by Norilsk Nickel. NKT is located within the license area held by TGK, Eurasia's 80% owned subsidiary in Kola, immediately to the north of the TGK-owned West Nittis open pit deposit already licenced for mining, where the mining plan has now been developed for the life of mine.

Highlights:

· Tier-1 scale: 305Kt of Nickel, 143Kt of Copper, 57 tons of PGM and Gold (11.2Moz of Platinum equivalent) have been estimated by WAI as JORC-compliant resources for an underground mining operation.

· Nickel is the main metal comprising half of the value in the metal basket on a Net Smelter Royalty ("NSR") basis.

· Although significantly lower metal recoveries have conservatively been assumed for the MRE by WAI, the JORC-compliant Nickel resource has exceeded the Nickel resource registered in the Russian State Cadastre of Mines for NKT (please refer to RNS dated 4 December 2019). Metal recoveries remain a significant upside for the next NKT MRE update.

· About 2/3 of the resources have been defined as reserves under Russian classification by Norilsk Nickel, however the drill core and the trenches have only been analysed for the base metals (Nickel and Copper) and have not been analysed for platinum group metals ("PGM") thus limiting the classification to inferred under the JORC Code due to the application of regression formulas for PGM. Once all the PGM assays have been completed, this data will be used for re-estimation and re-classification providing additional upside for the next NKT MRE update.

· In order to further upgrade the resource Eurasia has engaged with SGS and Alex Stewart International for primary and secondary controls of the PGM assays on the historical drill core and the trenches by Severonickel / Norilsk Nickel as well as on the additional confirmatory drilling just done by Eurasia on NKT.

· The NKT nickel-copper-PGM ore used to be mined and shipped about 1 km distance to Severonickel, the world's largest nickel processing plant. Thus, the NKT area is well served with the infrastructure required for the relaunch of mining and processing and the tailings are planned to be used as backfill to the old NKT mine developed in the past following the best practices in ESG and saving on the tailing storage facility ("TSF") capital expenditure.

· The Competent Person's Report ("CPR") has been prepared by WAI covering the open pit part of the NKT as well as the underground part of the NKT.

· Multiple options for the relaunch have be

TIDMEUA

RNS Number : 7421U

Eurasia Mining PLC

06 December 2021

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN EU REGULATION NO. 596/2014 (AS IT FORMS PART OF RETAINED EU LAW AS DEFINED IN THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) AND IS IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 7 OF THAT REGULATION.

6 December 2021

Eurasia Mining Plc

Binding Agreement Signed with ERDC

Eurasia Mining Plc ("Eurasia" or the "Company"), the palladium, platinum, rhodium, iridium and gold producing company, is pleased to announce that the Company's Kola subsidiary has signed a legally binding cooperation agreement ("ERDC Agreement") with the Russian state owned Far East and Arctic Region Development Corporation ("ERDC") which falls under the remit of the Russian Ministry for the Development of the Far East and Arctic. Establishing cooperation with ERDC with regard to all Eurasia's projects in the Kola Peninsula ("Kola") will allow Eurasia (whilst current majority owner of its Kola subsidiaries) to obtain further state support and various tax and non-tax benefits for both Eurasia's own projects and all the projects included in the agreement between the Company and Rosgeo (collectively "Kola Projects").

Due to their location in the Arctic Zone of the Russian Federation, the Kola Projects have been included in and will be significantly enhanced by the ERDC Agreement.

Impact of the ERDC Agreement on the Company

In accordance with the Russian Federal Law No. 193 of 13 July 2020 "On State Support of Business in the Arctic Zone of the Russian Federation" ("Law 193"), Kola being a part of the Murmansk Region, was included in the Arctic Zone of the Russian Federation ("Arctic"). Investor support in the Arctic is granted and managed through ERDC and the management company "The Capital of Arctic LLC", a joint venture of the Government of the Murmansk Region and ERDC that has the state mandate for business development and support of investment projects in the Arctic.

The main objectives of economic development in the Russian Arctic were defined in the "Strategy for the Development and National Security in the Arctic Zone of the Russian Federation for the period until 2035" (which covers the major part of the Kola Projects potential life of mine) and include the implementation of a special economic regime in the Arctic that promotes private investment in mining, creation of new and modernization of existing industrial facilities and the development of new mines. These tasks can be achieved through a series of measures, an example of which is the establishment of a simpler procedure of land allocation for mining in the Arctic.

Russian laws set out the scope of measures and instruments of i

“I just want to emphasize that I think it’s a pretty minimal benefit,” said Sally Hunsberger, a statistician at the Biometrics Research Branch of the National Institute of Allergy and Infectious Diseases, who voted no. “I don’t really think we know what groups this is benefiting, if it’s benefiting.”

With the efficacy of the drug far from a slam dunk, the safety profile of the pill became a central point of debate. Molnupiravir works by scrambling the genome of the coronavirus, resulting in catastrophic errors that disable it.

Some committee members said they feared that the drug’s mechanism could result in a more fearsome version of the virus.

“I voted no. It was an easy vote for me to vote no. … There were more questions than answers. I think the potential for this drug to drive some very challenging variants into the public is a major, major concern,” said James E.K. Hildreth, president of Meharry Medical College.

Molnupiravir has not yet been tested against the omicron variant, but because it works in a different way than vaccines and monoclonal antibodies that train their firepower on the coronavirus spike protein, it is expected to hold up against a wide range of variants.

Merck scientists have been testing the drug against every new variant, and have begun working on omicron, said Nicholas Kartsonis, senior vice president of clinical research for infectious diseases and vaccines at Merck. “We expect, based on what we know about the omicron variant, that molnupiravir would be effective against this particular variant,” he said.

But one committee member cautioned against assuming that the drug would be more variant-proof than vaccines or other treatments.

“If we take a look at the omicron variant and see the number of mutations that virus has, I think in many ways we don’t really understand which direction the virus may even be going in terms of changing,” said W. David Hardy, a scientific and medical consultant at Charles R. Drew University of Medicine and Science, who voted yes. “To assume this drug … is going to work when the monoclonals don’t is a big jump. We have no assurance of that.”

Even people who voted in favor of the drug pointed out that it would not be first in line if other options existed.

“If there is an alternative therapy that’s efficacious, like monoclonal antibodies currently or a future medication, that would be the priority,” said Uma M. Reddy, an obstetrician and maternal fetal medicine specialist at Yale School of Medicine, who voted yes.

A second oral pill regimen — it was developed by Pfizer — is also being reviewed by the FDA. That drug could offer advantages that will make it the choice of physicians: It was more effective at preventing hospitalization and death, and doesn’t carry safety concerns about its potential to cause mutations. In contrast, those fears led many committee members to say they would not prescribe the Merck drug to pregnant patients.

Well going by this report in the Washington Post,SNG 001 is a no brainer if the phase 3 results are anywhere near previous trials,I think the EUA efficiancy threshold just got a lot lower,some of the comments are pretty staggering!!

FDA advisers narrowly recommend authorization of first antiviral pill to treat covid-19

Molnupiravir could soon become the first easy-to-use pill to treat covid-19 authorized in the United States. (Merck/AP)
By Carolyn Y. Johnson and Katie Shepherd
Yesterday at 5:02 p.m. EST|Updated today at 7:51 p.m. EST

Expert advisers to the Food and Drug Administration recommended authorization Tuesday of the first coronavirus pill to prevent high-risk people from developing severe illness in a divided vote that reflects the complicated mix of benefits and risks involved with a new and easy mode of treatment.

FAQ: What to know about the omicron variant of the coronavirus
Merck and Ridgeback Biotherapeutics developed the drug, molnupiravir, as a five-day regimen to be taken at home within five days of onset of coronavirus symptoms. The FDA is not bound by the 13-to-10 vote but typically follows its external advisers’ recommendations. The drug could have an immediate impact on the pandemic if authorized — just as the ominous new omicron variant has emerged, jolting the world with the prospect of a longer and more complicated pandemic.

Merck has pledged to manufacture treatment courses for 10 million patients by the end of the year, and the United States has preordered enough medicine to treat 3.1 million people. Monoclonal antibodies, another treatment, are harder to administer but are more effective, which led experts to debate the benefits and drawbacks of an easy-to-use medicine that would offer an additional tool to reduce the strain on hospitals as a potential winter surge looms.

“I voted yes. This was clearly a very difficult decision,” said Michael Green, a professor of pediatrics at the University of Pittsburgh School of Medicine. “Should an alternative oral agent become available that had a better safety profile and equal to or better efficacy profile, the agency might reconsider its authorization.”

When preliminary data on the drug was released in early October, molnupiravir appeared to cut risk of death and hospitalization in half, a finding so persuasive that the trial was halted at its midpoint. After continued follow-up of patients, the drug appeared less impressive, with risk of death and hospitalization reduced by 30 percent — an unexplained erosion that was another factor in some committee members’ hesitancy to endorse the treatment.

“I just want to emphasize that I think it’s a pretty minimal benefit,” said Sally Hunsberger, a statistician at the Biometrics Research Branch of the National Institute of Allergy and Infectious Diseases, who voted no. “I don’t really think we know what groups this is benefiting, if it’s benefiting.”

With the efficacy of the drug far from a slam dunk,

Moscow - November 29, 2021 PJSC MMC Norilsk Nickel, the world's largest producer of palladium and high-grade nickel and a major producer of platinum and copper, hosted its annual Capital Markets Day.
This year has been another challenging year for Nornickel, as on top of the remaining COVID-related restrictions, the Company had to deal with two industrial incidents. Both operations, Norilsk concentrator and two temporarily flooded mines, have successfully recovered from these incidents by now.
The Company's environmental program has reached a number of new milestones in Kola division, whereas the delivery on the Sulphur Programme 2.0 in Norilsk division is on track. Nornickel has been successful at ramping up capex this year, which is expected to increase by more than 50% from 2020. The efforts which have been applied to support the expansion of capital investments in 2021, give us confidence in our ability to deliver on the new even more ambitious capex targets.
Our metals basket is absolutely critical to support the global transition to a net zero world. Core growth projects are on track and long-term production volume targets have been raised.
The management's strategic goal is to navigate Nornickel to the premier league of the future green economy and become a leader in sustainability. This means not just compliance with the national technical and legal requirements, but adherence to the industry's highest ESG standards.

Strategic challenges
In order to lead the transition to a 'green economy', Nornickel has to settle all legacy environmental issues such as sulphur dioxide emissions and legacy pollution. Managing climate change has become a separate item on the strategic agenda, with the focus put on the management of physical risks of operating in permafrost conditions, but also on opportunities for our commodity basket offered by the global decarbonization trend.
Achieving zero fatalities has been put on top of the strategic agenda alongside reduction of negative impact on local communities and a major revamp of the city of Norilsk residential and social infrastructure. The KPI system is being aligned with new ESG long- term priorities.
The Company is naturally positioned to lead the debottlenecking of the Russian Arctic transportation routes and unlock the enormous geologic potential of Taimyr Peninsula. We are planning to expand our transport infrastructure and improve our competitiveness in attracting and retaining the best talents in Norilsk.
Expansion of capital investments with a clear focus on ESG

ornickel has updated up its long-term CAPEX program through the year 2021-2030, raising it by USD 6 bn to USD 35 bn, of which approximately USD 6 bn will be allocated to environmental projects. Another major component of the revised capex plans is USD8bn investments into energy infrastructure, which include accelerated modernization of renewable energy assets, high-voltage transmission lines as well as investments in addition

Moscow - November 29, 2021 PJSC MMC Norilsk Nickel, the world's largest producer of palladium and high-grade nickel and a major producer of platinum and copper, hosted its annual Capital Markets Day.This year has been another challenging year for Nornickel, as on top of the remaining COVID-related restrictions, the Company had to deal with two industrial incidents. Both operations, Norilsk concentrator and two temporarily flooded mines, have successfully recovered from these incidents by now.The Company's environmental program has reached a number of new milestones in Kola division, whereas the delivery on the Sulphur Programme 2.0 in Norilsk division is on track. Nornickel has been successful at ramping up capex this year, which is expected to increase by more than 50% from 2020. The efforts which have been applied to support the expansion of capital investments in 2021, give us confidence in our ability to deliver on the new even more ambitious capex targets.Our metals basket is absolutely critical to support the global transition to a net zero world. Core growth projects are on track and long-term production volume targets have been raised.The management's strategic goal is to navigate Nornickel to the premier league of the future green economy and become a leader in sustainability. This means not just compliance with the national technical and legal requirements, but adherence to the industry's highest ESG standards.Strategic challengesIn order to lead the transition to a 'green economy', Nornickel has to settle all legacy environmental issues such as sulphur dioxide emissions and legacy pollution. Managing climate change has become a separate item on the strategic agenda, with the focus put on the management of physical risks of operating in permafrost conditions, but also on opportunities for our commodity basket offered by the global decarbonization trend.Achieving zero fatalities has been put on top of the strategic agenda alongside reduction of negative impact on local communities and a major revamp of the city of Norilsk residential and social infrastructure. The KPI system is being aligned with new ESG long- term priorities.The Company is naturally positioned to lead the debottlenecking of the Russian Arctic transportation routes and unlock the enormous geologic potential of Taimyr Peninsula. We are planning to expand our transport infrastructure and improve our competitiveness in attracting and retaining the best talents in Norilsk.Expansion of capital investments with a clear focus on ESGNornickel has updated up its long-term CAPEX program through the year 2021-2030, raising it by USD 6 bn to USD 35 bn, of which approximately USD 6 bn will be allocated to environmental projects. Another major component of the revised capex plans is USD8bn investments into energy infrastructure, which include accelerated modernization of renewable energy assets, high-voltage tran

Latest Share Chat

Member Info for dafad

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)

Latest Share Chat

Member Info for dafad

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending